Blue Steens newsletter icon

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed.

At a glance

In terms of COVID-19, hydroxychloroquine as a potential treatment has fallen further from favour whilst remdesivir is in high demand; dexamethasone has also stood its ground; 4 highly promising vaccines are now in late-stage development phases globally; and llama antibodies could potentially be engineered as anti-virals.

In addition, I noticed some other exciting stories about biotech developments. Replays to a few virtual events can be found at the end. By the way, I have started compiling my favourite replays and other relevant videos in a blockchain playlist on YouTube.

Click to read >>>